Medicare Price of Osimertinib 2023

Osimertinib (Osimertinib) has been approved for marketing by the National Medical Products Administration and has been included in the scope of Class B medical insurance through the regulations of the National Medical Insurance Bureau. The reimbursement conditions are limited to patients who meet the drug indications. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The price of the specification80mg*30 tablets per box is around RMB 5,000, which is relatively expensive.

Osimertinibcontains the active ingredientosimertinib,is a drug for the treatment of non-small cell lung cancer (NSCLC). It is used exclusively in patients whose cancer cells have certain mutations in a gene, a protein called EGFR. Patients whose cancer cells have Ex19del or L858R gene changes, and whose cancer has not spread to other organs and has been completely removed by surgery, are administered to help prevent cancer recurrence (adjuvant treatment). Patients whose cancer cells have mutations called "activating mutations." If the cancer is advanced or has spread, osimertinib is the first treatment option. If the cancer cells have the T790M mutation and the cancer is advanced or has spread, the drug may be given after other treatments.

The name of the original drug of osimertinib marketed in China is osimertinib mesylate tablets. The original drug of Osimertinib has also been launched overseas, and there are also generics of Osimertinib produced in other countries, such as the specifications produced by Bangladesh Yaopin InternationalThe price of each box of 80mg*30 tablets is around RMB 850 (the price may fluctuate due to the exchange rate), which is relatively cheap. The ingredients of the generic Osimertinib and the original drug are basically the same.